212 related articles for article (PubMed ID: 38405775)
1. Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal Dementia.
Hsiao-Nakamoto J; Chiu CL; VandeVrede L; Ravi R; Vandenberg B; De Groot J; Tsogtbaatar B; Fang M; Auger P; Gould NS; Marchioni F; Powers CA; Davis SS; Suh JH; Alkabsh J; Heuer HW; Lago AL; Scearce-Levie K; Seeley WW; Boeve BF; Rosen HJ; Berger A; Tsai R; Di Paolo G; Boxer AL; Bhalla A; Huang F;
bioRxiv; 2024 Feb; ():. PubMed ID: 38405775
[TBL] [Abstract][Full Text] [Related]
2. Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia.
Sogorb-Esteve A; Nilsson J; Swift IJ; Heller C; Bocchetta M; Russell LL; Peakman G; Convery RS; van Swieten JC; Seelaar H; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Tartaglia MC; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; Santana I; Butler CR; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Sorbi S; Le Ber I; Pasquier F; Gobom J; Brinkmalm A; Blennow K; Zetterberg H; Rohrer JD;
Alzheimers Res Ther; 2022 Aug; 14(1):118. PubMed ID: 36045450
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort.
Peakman G; Russell LL; Convery RS; Nicholas JM; Van Swieten JC; Jiskoot LC; Moreno F; Sanchez-Valle R; Laforce R; Graff C; Masellis M; Tartaglia MC; Rowe JB; Borroni B; Finger E; Synofzik M; Galimberti D; Vandenberghe R; de Mendonça A; Butler CR; Gerhard A; Ducharme S; Le Ber I; Tagliavini F; Santana I; Pasquier F; Levin J; Danek A; Otto M; Sorbi S; Rohrer JD;
J Neurol Neurosurg Psychiatry; 2022 Feb; 93(2):158-168. PubMed ID: 34353857
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
[TBL] [Abstract][Full Text] [Related]
5. CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia.
Woollacott IOC; Swift IJ; Sogorb-Esteve A; Heller C; Knowles K; Bouzigues A; Russell LL; Peakman G; Greaves CV; Convery R; Heslegrave A; Rowe JB; Borroni B; Galimberti D; Tiraboschi P; Masellis M; Tartaglia MC; Finger E; van Swieten JC; Seelaar H; Jiskoot L; Sorbi S; Butler CR; Graff C; Gerhard A; Laforce R; Sanchez-Valle R; de Mendonça A; Moreno F; Synofzik M; Vandenberghe R; Ducharme S; Ber IL; Levin J; Otto M; Pasquier F; Santana I; Zetterberg H; Rohrer JD;
Ann Clin Transl Neurol; 2022 Nov; 9(11):1764-1777. PubMed ID: 36245297
[TBL] [Abstract][Full Text] [Related]
6. Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study.
van der Ende EL; Heller C; Sogorb-Esteve A; Swift IJ; McFall D; Peakman G; Bouzigues A; Poos JM; Jiskoot LC; Panman JL; Papma JM; Meeter LH; Dopper EGP; Bocchetta M; Todd E; Cash D; Graff C; Synofzik M; Moreno F; Finger E; Sanchez-Valle R; Vandenberghe R; Laforce R; Masellis M; Tartaglia MC; Rowe JB; Butler C; Ducharme S; Gerhard A; Danek A; Levin J; Pijnenburg YAL; Otto M; Borroni B; Tagliavini F; de Mendonça A; Santana I; Galimberti D; Sorbi S; Zetterberg H; Huang E; van Swieten JC; Rohrer JD; Seelaar H;
J Neuroinflammation; 2022 Sep; 19(1):217. PubMed ID: 36064709
[TBL] [Abstract][Full Text] [Related]
7. Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants.
Staffaroni AM; Goh SM; Cobigo Y; Ong E; Lee SE; Casaletto KB; Wolf A; Forsberg LK; Ghoshal N; Graff-Radford NR; Grossman M; Heuer HW; Hsiung GR; Kantarci K; Knopman DS; Kremers WK; Mackenzie IR; Miller BL; Pedraza O; Rascovsky K; Tartaglia MC; Wszolek ZK; Kramer JH; Kornak J; Boeve BF; Boxer AL; Rosen HJ;
JAMA Netw Open; 2020 Oct; 3(10):e2022847. PubMed ID: 33112398
[TBL] [Abstract][Full Text] [Related]
8. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
[TBL] [Abstract][Full Text] [Related]
9. Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations.
Huang M; Modeste E; Dammer E; Merino P; Taylor G; Duong DM; Deng Q; Holler CJ; Gearing M; Dickson D; Seyfried NT; Kukar T
Acta Neuropathol Commun; 2020 Oct; 8(1):163. PubMed ID: 33028409
[TBL] [Abstract][Full Text] [Related]
10. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.
Heller C; Foiani MS; Moore K; Convery R; Bocchetta M; Neason M; Cash DM; Thomas D; Greaves CV; Woollacott IO; Shafei R; Van Swieten JC; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonca A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Frisoni G; Sorbi S; Otto M; Heslegrave AJ; Zetterberg H; Rohrer JD;
J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):263-270. PubMed ID: 31937580
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Cognitive Changes in Genetic Frontotemporal Dementia Within the GENFI Cohort.
Poos JM; MacDougall A; van den Berg E; Jiskoot LC; Papma JM; van der Ende EL; Seelaar H; Russell LL; Peakman G; Convery R; Pijnenburg YAL; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Doré MC; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; Mendonça A; Tiraboschi P; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Le Ber I; Pasquier F; van Swieten J; Rohrer JD;
Neurology; 2022 Jul; 99(3):e281-e295. PubMed ID: 35483895
[TBL] [Abstract][Full Text] [Related]
12. Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations.
Davis SE; Cook AK; Hall JA; Voskobiynyk Y; Carullo NV; Boyle NR; Hakim AR; Anderson KM; Hobdy KP; Pugh DA; Murchison CF; McMeekin LJ; Simmons M; Margolies KA; Cowell RM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Arrant AE
Acta Neuropathol Commun; 2023 Apr; 11(1):70. PubMed ID: 37118844
[TBL] [Abstract][Full Text] [Related]
13. Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics.
van der Ende EL; Meeter LH; Stingl C; van Rooij JGJ; Stoop MP; Nijholt DAT; Sanchez-Valle R; Graff C; Öijerstedt L; Grossman M; McMillan C; Pijnenburg YAL; Laforce R; Binetti G; Benussi L; Ghidoni R; Luider TM; Seelaar H; van Swieten JC
Ann Clin Transl Neurol; 2019 Apr; 6(4):698-707. PubMed ID: 31019994
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
Woollacott IOC; Nicholas JM; Heslegrave A; Heller C; Foiani MS; Dick KM; Russell LL; Paterson RW; Keshavan A; Fox NC; Warren JD; Schott JM; Zetterberg H; Rohrer JD
Alzheimers Res Ther; 2018 Aug; 10(1):79. PubMed ID: 30111356
[TBL] [Abstract][Full Text] [Related]
15. A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort.
Moore K; Convery R; Bocchetta M; Neason M; Cash DM; Greaves C; Russell LL; Clarke MTM; Peakman G; van Swieten J; Jiskoot L; Moreno F; Barandiaran M; Sanchez-Valle R; Borroni B; Laforce R; Doré MC; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Karnath HO; Vandenberghe R; de Mendonça A; Maruta C; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Warren JD; Rohrer JD;
Appl Neuropsychol Adult; 2022; 29(1):112-119. PubMed ID: 32024404
[TBL] [Abstract][Full Text] [Related]
16. Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia.
van der Ende EL; Xiao M; Xu D; Poos JM; Panman JL; Jiskoot LC; Meeter LH; Dopper EG; Papma JM; Heller C; Convery R; Moore K; Bocchetta M; Neason M; Peakman G; Cash DM; Teunissen CE; Graff C; Synofzik M; Moreno F; Finger E; Sánchez-Valle R; Vandenberghe R; Laforce R; Masellis M; Tartaglia MC; Rowe JB; Butler CR; Ducharme S; Gerhard A; Danek A; Levin J; Pijnenburg YA; Otto M; Borroni B; Tagliavini F; de Mendonca A; Santana I; Galimberti D; Seelaar H; Rohrer JD; Worley PF; van Swieten JC;
J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):612-621. PubMed ID: 32273328
[TBL] [Abstract][Full Text] [Related]
17. Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images.
Whitwell JL; Boeve BF; Weigand SD; Senjem ML; Gunter JL; Baker MC; DeJesus-Hernandez M; Knopman DS; Wszolek ZK; Petersen RC; Rademakers R; Jack CR; Josephs KA
Eur J Neurol; 2015 May; 22(5):745-52. PubMed ID: 25683866
[TBL] [Abstract][Full Text] [Related]
18. Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations.
Bouzigues A; Russell LL; Peakman G; Bocchetta M; Greaves CV; Convery RS; Todd E; Rowe JB; Borroni B; Galimberti D; Tiraboschi P; Masellis M; Tartaglia MC; Finger E; van Swieten JC; Seelaar H; Jiskoot L; Sorbi S; Butler CR; Graff C; Gerhard A; Langheinrich T; Laforce R; Sanchez-Valle R; de Mendonça A; Moreno F; Synofzik M; Vandenberghe R; Ducharme S; Le Ber I; Levin J; Danek A; Otto M; Pasquier F; Santana I; Rohrer JD;
J Neurol; 2022 Aug; 269(8):4322-4332. PubMed ID: 35348856
[TBL] [Abstract][Full Text] [Related]
19. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.
Dopper EG; Chalos V; Ghariq E; den Heijer T; Hafkemeijer A; Jiskoot LC; de Koning I; Seelaar H; van Minkelen R; van Osch MJ; Rombouts SA; van Swieten JC
Neuroimage Clin; 2016; 12():460-5. PubMed ID: 27625986
[TBL] [Abstract][Full Text] [Related]
20. Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression.
Khrouf W; Saracino D; Rucheton B; Houot M; Clot F; Rinaldi D; Vitor J; Huynh M; Heng E; Schlemmer D; Pasquier F; Deramecourt V; Auriacombe S; Azuar C; Levy R; Bombois S; Boutoleau-Brétonnière C; Pariente J; Didic M; Wallon D; Fluchère F; Auvin S; Younes IB; ; ; Nadjar Y; Brice A; Dubois B; Bonnefont-Rousselot D; Le Ber I; Lamari F
Neurobiol Dis; 2023 Jun; 181():106108. PubMed ID: 37003407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
